Related Experiment Video

Updated: Sep 6, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Neonatal jaundice

A Amanullah

    American Journal of Diseases of Children (1960)
    |November 1, 1976
    PubMed

    Insights

    This article reviews newborn hyperbilirubinemia, differentiating causes and management for unconjugated and conjugated types. Early diagnosis and treatment of conjugated hyperbilirubinemia, caused by liver dysfunction or biliary obstruction, are emphasized.

    Area of Science:

    • Neonatology
    • Pediatric Gastroenterology
    • Biochemistry

    Background:

    • Neonatal hyperbilirubinemia is common, with distinct causes for unconjugated and conjugated forms.
    • Understanding these differences is crucial for appropriate clinical management.
    • Conjugated hyperbilirubinemia requires prompt evaluation due to potential underlying pathology.

    Purpose of the Study:

    • To review the production, transport, and excretion of bilirubin in newborns.
    • To differentiate the causes, significance, and treatment of unconjugated and conjugated hyperbilirubinemia.
    • To highlight recent advances in managing conjugated hyperbilirubinemia.

    Main Methods:

    • Literature review focusing on bilirubin metabolism in neonates.
    • Comparative analysis of unconjugated and conjugated hyperbilirubinemia.
    • Discussion of diagnostic and therapeutic strategies.

    Main Results:

    • Unconjugated hyperbilirubinemia has distinct etiologies and management compared to conjugated forms.
    • Conjugated hyperbilirubinemia in newborns can stem from hepatocellular dysfunction or extrahepatic biliary obstruction.
    • Early differentiation between these two causes of conjugated hyperbilirubinemia is critical.

    Conclusions:

    • Effective management of neonatal hyperbilirubinemia hinges on accurate diagnosis of its type.
    • Prompt identification and treatment of conjugated hyperbilirubinemia are essential to address underlying liver or biliary issues.
    • Advances in diagnostic tools facilitate earlier and more precise management of neonatal conjugated hyperbilirubinemia.

    More Related Videos

    Isolation of Neonatal Extrahepatic Cholangiocytes07:54

    Isolation of Neonatal Extrahepatic Cholangiocytes

    Published on: June 5, 2014

    How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

    How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

    Published on: August 19, 2020

    Related Concept Videos

    Pigmentation01:19

    Pigmentation

    The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
    Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
    Changes in Skin Color: Clinical Perspectives01:14

    Changes in Skin Color: Clinical Perspectives

    The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
    Albinism
    Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Diseases of the Liver and Gallbladder01:26

    Diseases of the Liver and Gallbladder

    Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
    Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
    Inborn Errors of Metabolism01:20

    Inborn Errors of Metabolism

    Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
    Jaundice01:25

    Jaundice

    Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...